Halo to Postpone Reporting Interim Financial Results Due to Delays Caused by the COVID-19 Pandemic

Nachrichtenquelle: Business Wire (engl.)
14.08.2020, 22:15  |  1823   |   |   

Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announces that, due to delays caused by the COVID-19 pandemic, it is relying on the exemption provided in Ontario Instrument 51-505 - Temporary Exemption from Certain Corporate Finance Requirements with Deadlines during the Period from June 2 to August 31, 2020 (the "Instrument") of the Ontario Securities Commission (and similar exemptions provided by other Canadian securities regulators) to postpone the filing of the following continuous disclosure documents (collectively, the "Disclosure Documents"):

  • the Company's interim financial statements for the three and six months ended June 30, 2020 as required by section 4.4(a) of National Instrument 51-102 – Continuous Disclosure Obligations ("NI 51-102"); and
  • the Company's management discussion & analysis for the three and six months ended June 30, 2020 as required by subsection 5.1(2) of NI 51-102.

The Instrument provides the Company with an additional 45 days from the deadline otherwise applicable under Ontario securities laws to make the filing. The Company’s management and other insiders are subject to a trading blackout reflecting the principles contained in section 9 of National Policy 11-207 – Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions.

The Company expects to file the Disclosure Documents on or prior to August 18, 2020.

The Company confirms that, other than as disclosed in prior press releases, there have been no additional material business developments since the filing on June 19, 2020 of the Company's interim financial report for the three months ended March 31, 2020.

About Halo

Halo is a leading cannabis cultivation, manufacturing, and distribution company that grows and extracts and processes quality cannabis flower, oils, and concentrates and has sold over 5 million grams of oils and concentrates since inception. Additionally, Halo has continued to evolve its business through delivering value with its products and now via verticalization in key markets in the United States and Africa with planned expansion into European and Canadian markets. With a consumer-centric focus, Halo markets innovative, branded, and private label products across multiple product categories.

Seite 1 von 3
Halo Labs Aktie jetzt ab 0€ handeln - auf Smartbroker.de

Diesen Artikel teilen

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel